The analyzed data (CGGA mRNA_301, CGGA mRNA_325, and CGGA mRNA_693) indicated that glioma patients with the IDH_mutation attribute exhibited lower SYDE1 expression than patients with IDH_wildtype (p < 0.001, Figures 6F–H). This evidence concerns the gene IDH1 and central nervous system cancer.